您好，歡迎來到拜力生物網(wǎng)站！請登錄注冊

我的訂單 | 聯(lián)系我們 | 在線客服QQ：3012681483 | 客服電話：400-968-7988 | 工作時間：08:30-17:30

主營產(chǎn)品： ELISA試劑盒、抗體、補體血清、兔補體、干擾素、小鼠測溫儀、進口試劑、Quidel代理、Swant代理、PBL Assay Science代理

網(wǎng)站首頁產(chǎn)品中心代理品牌新聞資訊資源中心關于我們

所在位置：首頁 > 產(chǎn)品中心 > CheMatech-mdt > CheMatech-mdt**前MRI探針

訂購信息

上海拜力生物科技公司

Tel:400-968-7988 021-33779008

P792 – Vistarem? (Gadomelitol)

品牌：CheMatech

貨號：Preclinical MRI probes

規(guī)格：

貨期：

應用：

咨詢客服

立即購買加入購物車

HomePreclinical MRI probesP792 – Vistarem? (Gadomelitol) P792 – Vistarem? (Gadomelitol) 470.00 €? Category: Preclinical MRI probes?

商品詳情參考文獻相關資料

P792 – Vistarem® (Gadomelitol)

470.00 €

Category: Preclinical MRI probes

Description

Catalogue Number

P792

Description

Monogadolinated MRI blood-pool agent of 5 nm diameter. Pharmacokinetics and biodistribution profiles consistent with a rapid-clearance blood-pool agent (RCBPA): mainly excreted by glomerular filtration with limited diffusion across normal endothelium

Main Applications

DCE-MRI (Ktrans modeling, tumoral characterization / treatment follow up), high resolution contrast-enhanced MR angiography (MRA), myocardial perfusion, arthrography, myocardial perfusion and viability

Molecular characteristics

– Hydrodynamic size: diameter is approximately 5 nm (compared to ?1 nm for Gd-DOTA)
– Gd content: 1 atom per particle

– Molecular weight: 6.5 kDa

– Recommended dose: 50 μmol/kg = 2.5 μL/g

Example: for a 30g body weight mouse, injection volume is 75 μL

– Relaxivities (s-1.mM-1, 37°C, 4% Human Albumin Serum)

Bo(T)	1.5	2.35	3.0	4.7	7.0
r1	27	15	12	7	5
r2	68	67	68	66	63

Characteristics of the vial

– Concentration: [Gd] = 20 mmol/L
– Volume: 450 μL (5 mice dose approx.)
– Other animal species: please contact us

Storage

Need to be stored at 4°C in a closed vial and away from light

Notes

For in vitro or animal use only

Selected publications

[1] Ceelen W et al. Br J Cancer 2007 [2] Dewey et al.Investigative Radiology 2004 [3] Watrin Pinzano A et al. Biomed Mater Eng 2008 [4] Ruehm et al. Magnetic Resonance in Medicine 2002 [5] Dirksen MS et al. Eur Radiol 2003 [6] Herborn CU et al. Invest Rad